产品资料

重组人UBE2I, His

如果您对该产品感兴趣的话,可以
产品名称: 重组人UBE2I, His
产品型号: PP1002158-10μg
产品展商: PERFEMIKER
产品价格: 600.00 元
会员价格: 0.00 元
产品文档: 无相关文档
我要买:
产品已经成功添加到购物车
你添加了1件产品 查看购物车

简单介绍

名称:重组人UBE2I, His 货号:PP1002158 规格:10μg


重组人UBE2I, His  的详细介绍

名称:重组人UBE2I, His

Synonyms:SUMO-protein Ligase, Ubiquitin Carrier Protein 9, Ubiquitin Carrier Protein I, Ubiquitin-conjugating Enzyme E2 I, Ubiquitin-protein Ligase I, p18

Species:9

Source:Escherichia coli.

Molecular Weight:Approximately 19.5 kDa, a single non-glycosylated polypeptide chain containing 158 amino acids (a.a.) of human UBE2I/UBC9 and 8 a.a. vector sequence including 6 × His tag at N-terminus.

Quantity:10µg/50µg/1000µg

AA Sequence:MHHHHHHAMG TLNMSGIALS RLAQERKAWR KDHPFGFVAV PTKNPDGTMN LMNWECAIPG KKGTPWEGGL FKLRMLFKDD YPSSPPKCKF EPPLFHPNVY PSGTVCLSIL EEDKDWRPAI TIKQILLGIQ ELLNEPNIQD PAQAEAYTIY CQNRVEYEKR VRAQAKKFAP S

Concentration:See label.

Purity:> 95 % by SDS-PAGE and HPLC analyses.

Biological Activity:Data is not available.

Physical Appearance:Sterile Colorless liquid.

Formulation:A 0.2 µm filtered concentrated solution in 50 mM HEPES, pH 7.6, with 125 mM NaCl, 10 % Glycerol, 1 mM DTT.

Endotoxin:Less than 1 EU/µg of rHuUBC9, His as determined by LAL method.

Stability & Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 6 months from date of receipt, -20 to -70 °C as supplied.
- 3 months, -20 to -70 °C under sterile conditions after opening.

Reference:1. Yukita A, Hosoya A, Ito Y, et al. 2012. Bone, 50: 1092-9.
2. Duan X, Trent JO, Ye H. 2009. Anticancer Agents Med Chem, 9: 51-4.
3. Niedenthal R. 2009. Methods Mol Biol, 497: 63-79.
4. Shang Q, Xu C, Zhang J, et al. 2009. Proteins, 76: 266-9.

Background:SUMO-Conjugating Enzyme UBC9 belongs to the ubiquitin-conjugating enzyme family and is encoded by the UBE2I gene in humans. The ubiquitin-conjugating enzymes, also known as E2 enzymes and more rarely as ubiquitin-carrier enzymes, take part in the second step in the ubiquitination reaction. In this reaction, E1 activates the ubiquitin by covalently attaching the molecule to its active site cysteine residue. The activated ubiquitin is then transferred to an E2 cysteine and then the E2 molecule binds E3 via a structurally conserved binding region. The UBC9 accepts the ubiquitin-like proteins SUMO1-4 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2 or CBX4. Additionally, It takes parts in catalysis the formation of poly-SUMO chains, sumoylation of FOXL2 and KAT5, and the segregation of nuclear architecture and chromosome.

SDS-PAGE: